These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6113769)

  • 1. Breast cancer in hospitalized psychiatric patients.
    Goode DJ; Corbett WT; Schey HM; Suh SH; Woodie B; Morris DL; Morrisey L
    Am J Psychiatry; 1981 Jun; 138(6):804-6. PubMed ID: 6113769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.
    Froes Brandao D; Strasser-Weippl K; Goss PE
    Cancer; 2016 Jan; 122(2):184-8. PubMed ID: 26457577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs: An Observational Study of US Women (Ages 18-64 Years).
    Rahman T; Sahrmann JM; Olsen MA; Nickel KB; Miller JP; Ma C; Grucza RA
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):7-16. PubMed ID: 34864772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and smoking status in antipsychotic-treated patients.
    Mackin P; Waton A; Nulkar A; Watkinson HM
    J Psychopharmacol; 2011 May; 25(5):698-703. PubMed ID: 20699354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin response to neuroleptics. Clinical and theoretical implications.
    Ohman R; Axelsson R
    J Neural Transm Suppl; 1980; 17():1-74. PubMed ID: 6133911
    [No Abstract]   [Full Text] [Related]  

  • 6. Are dopamine antagonists a risk factor for breast cancer? An answer from Parkinson's disease.
    Lalonde FM; Myslobodsky M
    Breast; 2003 Aug; 12(4):280-2. PubMed ID: 14659314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole prescribing and continuation rates during psychiatric hospitalization.
    Coley KC
    Ann Pharmacother; 2005; 39(7-8):1367-8. PubMed ID: 15956242
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast and other cancer deaths in a mental hospital.
    Costa D; Mesteş E; Coban A
    Neoplasma; 1981; 28(3):371-8. PubMed ID: 6117020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic treatment in breast cancer patients.
    Rahman T; Clevenger CV; Kaklamani V; Lauriello J; Campbell A; Malwitz K; Kirkland RS
    Am J Psychiatry; 2014 Jun; 171(6):616-21. PubMed ID: 24880509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine antagonists and the development of breast cancer.
    Wang PS; Walker AM; Tsuang MT; Orav EJ; Glynn RJ; Levin R; Avorn J
    Arch Gen Psychiatry; 2002 Dec; 59(12):1147-54. PubMed ID: 12470131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.
    Bushe C; Yeomans D; Floyd T; Smith SM
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):56-62. PubMed ID: 18477621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are chronic psychiatric patients at increased risk for developing breast cancer?
    Halbreich U; Shen J; Panaro V
    Am J Psychiatry; 1996 Apr; 153(4):559-60. PubMed ID: 8599407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
    Centorrino F; Ventriglio A; Vincenti A; Talamo A; Baldessarini RJ
    Hum Psychopharmacol; 2010 Mar; 25(2):179-86. PubMed ID: 20196186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital.
    Pope HG; Keck PE; McElroy SL
    Am J Psychiatry; 1986 Oct; 143(10):1227-33. PubMed ID: 2876647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of long term phenothiazine therapy on plasma prolactin.
    Wilson RG; Hamilton JR; Boyd WD; Forrest AP; Cole EN; Boyns AR; Griffiths K
    Br J Psychiatry; 1975 Jul; 127():71-4. PubMed ID: 237595
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
    Schyve PM; Smithline F; Meltzer HY
    Arch Gen Psychiatry; 1978 Nov; 35(11):1291-1301. PubMed ID: 30426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin and breast cancer risk.
    Beumont PJ
    Med J Aust; 1991 Feb; 154(3):219. PubMed ID: 1671167
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.